The results showed that Bevacizumab upregulated 37 genes promoting ferroptosis, and downregulated 7 genes that inhibit ferroptosis, indicating that ferroptosis induced by anti-VEGF drugs has important anti-tumor effects (Hou et al. 2024). The gene discussed is VEGFA; the disease is neoplasm.